Articles tagged with Parkinsons Disease
Comprehensive exploration of living organisms, biological systems, and life processes across all scales from molecules to ecosystems. Encompasses cutting-edge research in biology, genetics, molecular biology, ecology, biochemistry, microbiology, botany, zoology, evolutionary biology, genomics, and biotechnology. Investigates cellular mechanisms, organism development, genetic inheritance, biodiversity conservation, metabolic processes, protein synthesis, DNA sequencing, CRISPR gene editing, stem cell research, and the fundamental principles governing all forms of life on Earth.
Comprehensive medical research, clinical studies, and healthcare sciences focused on disease prevention, diagnosis, and treatment. Encompasses clinical medicine, public health, pharmacology, epidemiology, medical specialties, disease mechanisms, therapeutic interventions, healthcare innovation, precision medicine, telemedicine, medical devices, drug development, clinical trials, patient care, mental health, nutrition science, health policy, and the application of medical science to improve human health, wellbeing, and quality of life across diverse populations.
Comprehensive investigation of human society, behavior, relationships, and social structures through systematic research and analysis. Encompasses psychology, sociology, anthropology, economics, political science, linguistics, education, demography, communications, and social research methodologies. Examines human cognition, social interactions, cultural phenomena, economic systems, political institutions, language and communication, educational processes, population dynamics, and the complex social, cultural, economic, and political forces shaping human societies, communities, and civilizations throughout history and across the contemporary world.
Fundamental study of the non-living natural world, matter, energy, and physical phenomena governing the universe. Encompasses physics, chemistry, earth sciences, atmospheric sciences, oceanography, materials science, and the investigation of physical laws, chemical reactions, geological processes, climate systems, and planetary dynamics. Explores everything from subatomic particles and quantum mechanics to planetary systems and cosmic phenomena, including energy transformations, molecular interactions, elemental properties, weather patterns, tectonic activity, and the fundamental forces and principles underlying the physical nature of reality.
Practical application of scientific knowledge and engineering principles to solve real-world problems and develop innovative technologies. Encompasses all engineering disciplines, technology development, computer science, artificial intelligence, environmental sciences, agriculture, materials applications, energy systems, and industrial innovation. Bridges theoretical research with tangible solutions for infrastructure, manufacturing, computing, communications, transportation, construction, sustainable development, and emerging technologies that advance human capabilities, improve quality of life, and address societal challenges through scientific innovation and technological progress.
Study of the practice, culture, infrastructure, and social dimensions of science itself. Addresses how science is conducted, organized, communicated, and integrated into society. Encompasses research funding mechanisms, scientific publishing systems, peer review processes, academic ethics, science policy, research institutions, scientific collaboration networks, science education, career development, research programs, scientific methods, science communication, and the sociology of scientific discovery. Examines the human, institutional, and cultural aspects of scientific enterprise, knowledge production, and the translation of research into societal benefit.
Comprehensive study of the universe beyond Earth, encompassing celestial objects, cosmic phenomena, and space exploration. Includes astronomy, astrophysics, planetary science, cosmology, space physics, astrobiology, and space technology. Investigates stars, galaxies, planets, moons, asteroids, comets, black holes, nebulae, exoplanets, dark matter, dark energy, cosmic microwave background, stellar evolution, planetary formation, space weather, solar system dynamics, the search for extraterrestrial life, and humanity's efforts to explore, understand, and unlock the mysteries of the cosmos through observation, theory, and space missions.
Comprehensive examination of tools, techniques, methodologies, and approaches used across scientific disciplines to conduct research, collect data, and analyze results. Encompasses experimental procedures, analytical methods, measurement techniques, instrumentation, imaging technologies, spectroscopic methods, laboratory protocols, observational studies, statistical analysis, computational methods, data visualization, quality control, and methodological innovations. Addresses the practical techniques and theoretical frameworks enabling scientists to investigate phenomena, test hypotheses, gather evidence, ensure reproducibility, and generate reliable knowledge through systematic, rigorous investigation across all areas of scientific inquiry.
Study of abstract structures, patterns, quantities, relationships, and logical reasoning through pure and applied mathematical disciplines. Encompasses algebra, calculus, geometry, topology, number theory, analysis, discrete mathematics, mathematical logic, set theory, probability, statistics, and computational mathematics. Investigates mathematical structures, theorems, proofs, algorithms, functions, equations, and the rigorous logical frameworks underlying quantitative reasoning. Provides the foundational language and tools for all scientific fields, enabling precise description of natural phenomena, modeling of complex systems, and the development of technologies across physics, engineering, computer science, economics, and all quantitative sciences.
A cheap and easy way to treat Parkinson disease involves infusing the ketone body D-beta-HB, which restores mitochondrial respiration and protects against neurodegeneration. This novel therapy supports a critical role for mitochondrial defect in Parkinson disease and offers new hope for treatment.
Silverman's research focuses on inhibiting an enzyme that produces nitric oxide, a compound linked to high blood pressure, stroke, and neurological diseases. His work aims to block the overproduction of nitric oxide in the brain without affecting its normal function.
A new study finds that istradefylline, an adenosine A2A receptor antagonist, improves motor function in Parkinson's disease patients with reduced dyskinesias. The medication reduces the time patients experience tremors, slowness, and stiffness by up to 1.7 hours per day
A study of 1,884 Parkinson's patients found that nine developed pathological gambling, with most taking high doses of dopamine agonists. The condition was often linked to financial problems and could be controlled with treatment changes.
Researchers are exploring neural transplantation as a potential treatment for Parkinson's disease, despite initial disappointing results from clinical trials. Further studies aim to improve the effectiveness of transplants and address concerns about side effects such as dyskinesias.
A study of 250 newly diagnosed patients and 388 healthy individuals found that those with high iron intake were 1.7 times more likely to have Parkinson's disease. The study suggests that eating foods rich in iron and manganese may help prevent the disease.
Researchers found that head injury significantly increases risk of developing Parkinson's disease, with severe injuries linked to a 20-year delay in symptoms. The study suggests that mild head injuries may not be associated with an increased risk, but more research is needed to understand the link.
Researchers found high levels of COX-2 in dopamine neurons of Parkinson's patients, leading to cell death. Inhibiting the enzyme with a COX-2 inhibitor increased surviving neurons by up to 88%. The study suggests COX-2 inhibitors may slow disease progression and is being tested in new trials.
The study found a specific genetic risk factor, the J haplogroup, to be protective against Parkinson's disease, particularly in white women. The researchers also discovered that this variant is more common in people with lower incidences of the disease.
Two new studies presented at the American Academy of Neurology meeting found that ARICEPT treatment improved cognition in patients with mild cognitive impairment (MCI) and reduced behavioral symptoms in those with Parkinson's-related dementia. These findings provide encouraging news for millions of Americans affected by MCI.
A longitudinal study found that high fruit and fruit drink consumption predicted an increased risk of Parkinson's disease. However, vitamin C intake was not associated with the risk. The study suggests further research into food-borne toxins may help understand the etiology and prevention of the disease.
A new study suggests that early levodopa treatment may slow the rate of progression in Parkinson's disease. Levodopa treatment showed improved outcomes in patients with early Parkinson's disease compared to placebo.
A two-year follow-up study shows participants with advanced PD experienced improvements in tremor, stiffness, slow movement, and balance. The new cell therapy, Spheramine, provided a source of increased dopamine production, maintaining initial gains up to 24 months post-treatment.
A study involving 34 Parkinson's patients found that the implant improved their quality of life by an average of 22 percent, with significant improvements in mobility and motor functioning. Patients reported substantial improvements in daily activities such as dressing and preparing meals.
A new study reports remarkable improvements in motor skills and dopamine storage in five Parkinson's patients. The treatment, which administered GDNF directly into the brain, showed a 39% improvement in motor skills and 61% improvement in daily living activities.
Researchers have made a groundbreaking discovery by detecting Parkinson's symptoms on brain scans of living patients. The study, led by Dr. Robert Y. Moore, found positive evidence of nerve cell degeneration in areas controlling attention and wakefulness using PET scans.
Researchers found low-dose exposure to permethrin triggered a process with early onset and persistent effects, while high-level exposures had delayed effects. The study suggests that genetic predisposition may increase the risk of damage from pesticide exposure.
The study found that complex interactions between common gene variants contribute to Parkinson's disease risk in women. Environmental exposures are thought to play a greater role in men, with estrogen reducing the risk of developing the disease in women.
Researchers have discovered a way to control 'badly' behaving neurons in Parkinson's disease, potentially easing symptoms and progression. By blocking potassium channels or eliminating the subunit using gene therapy, high-frequency spiking can be stopped, preserving normal neuronal activity.
Researchers found a significant association between moderate caffeine consumption and reduced risk of Parkinson's disease in postmenopausal women who don't use hormone replacement therapy. However, high caffeine intake increased the risk of PD in women using HRT, suggesting an estrogen-caffeine interaction
The American Academy of Neurology has launched a new online section providing patients and caregivers with practical health care information on various neurological conditions. The Patient Page section aims to give the public access to accurate and reliable information through articles written by practicing neurologists.
A study published in Archives of Neurology found that Parkinson's patients treated with levodopa have higher levels of homocysteine, a risk factor for heart disease and dementia. The study suggests that monitoring homocysteine levels may be necessary for patients at risk of heart disease.
Bradford Parkinson, a pioneer of GPS technology, has been awarded the 2003 Charles Stark Draper Prize for his significant contributions to the development of the original GPS system architecture. He is also recognized for his work on improving GPS accuracy and its applications in various fields.
The study reveals that protein components in the post-synaptic density (PSD) move together in response to neural activity, with a significant percentage undergoing up-and-down regulation. The findings also suggest a high rate of PSD remodeling, with neurons replacing its content multiple times a day.
Researchers discovered that a mutated gene associated with early onset dystonia helps manage protein folding and is normally used as a quality control mechanism. TorsinA's failure to function correctly may lead to protein aggregation, causing neuron malfunction, which is linked to various movement disorders.
A new mouse genetic model exhibits a non-lethal form of spongiform brain disease, characterized by fluid-filled vacuoles and tissue degeneration. The mice lack the same motor coordination problems as affected cattle and are not contagious.
Dr. Ted Fon, a renowned Parkinson's Disease researcher, has been awarded a significant grant by the Michael J. Fox Foundation to investigate the role of protein degradation in the disease. The grant aims to enhance understanding of parkin function and its potential impact on dopamine nerve cell death.
Researchers have found a new Parkinson's drug to be effective in improving symptoms, with participants receiving 1mg of Rasagiline showing significant improvements compared to those on 2mg. The study calls for further research to evaluate the long-term effects of Rasagiline on the progression of the disease.
A new testing method for Huntington's disease (HSS) has been discovered by researchers at Oregon Health & Science University and UCSF. The test uses magnetic resonance imaging (MRI) to identify the 'eye of the tiger sign' in patients with PANK2 mutations, a gene linked to HSS and Parkinson's disease.
New research from University of Minnesota presents promising findings on unrelated donor transplants, including a study showing improved survival rates and quality of life for leukemia/lymphoma patients. Another study explores the use of bone marrow-derived stem cells to treat Parkinson's disease.
A study of Parkinson's patients found that those with advanced disease are at greater risk for motor vehicle collisions due to motor and cognitive dysfunction. The study also revealed no correlation between self-reported moving violations and total collisions on the simulator.
A new class of drugs may prevent neurodegenerative disorders by fortifying neurons before disease onset. Geldanamycin, a natural antibiotic, boosts molecular chaperone activity, protecting against alpha-synuclein toxicity in Parkinson's disease.
Researchers at Thomas Jefferson University have successfully converted human neural stem cells into dopamine-making neurons in a laboratory setting. Approximately 25% of the stem cells were able to produce the enzyme tyrosine hydroxylase, which is necessary for dopamine production. The breakthrough could potentially lead to the develop...
Researchers have found that high-frequency stimulation of the brain can alleviate obsessive-compulsive disorder (OCD) symptoms in patients with Parkinson's disease. Two patients who underwent electrode implantation showed significant improvement in compulsive behaviors, suggesting a potential therapeutic approach for severe OCD.
A large cohort study found that high dietary vitamin E intake was associated with a significantly lower risk of developing Parkinson's disease. However, the use of vitamin E or C supplements and multivitamins showed no protective effect on Parkinson's risk. The results suggest that other lifestyle factors may also play a role in reduci...
A national clinical trial with 80 Parkinson's patients showed that high-dose coenzyme Q10 slowed functional decline by 44%, particularly in everyday activities. The therapy needs to be tested in a larger trial before it can be recommended.
A phase II study found that coenzyme Q10 can slow the rate of functional decline in Parkinson's disease by improving mitochondrial function and energy-producing reactions. The study showed that higher doses of coenzyme Q10, up to 1,200 mg/day, were safe and more effective than lower doses.
Researchers have developed a new surgical procedure for Parkinson's disease, bilateral subthalamotomy, which has shown promising results in improving motor symptoms and activities of daily living. After two years of follow-up, patients exhibited approximately 50% improvement in motor symptoms and significant reduction in medication doses.
A landmark study shows that high doses of coenzyme Q10 can slow the progression of Parkinson's disease, measured by movement difficulty or disability. The study found significant reductions in motor disabilities, mental function, and mood among participants taking the nutrient.
Researchers successfully used gene therapy to change the brain's circuitry in rats with Parkinson's disease, producing nearly 70% fewer symptoms. The treatment involves altering glutamate and GABA signaling pathways to protect dopamine neurons from deterioration.
A new study using gene therapy has shown promise in treating Parkinson's disease by 'resetting' overactive brain cells. The therapy may arrest or delay disease progression, offering a safer and more powerful alternative to current treatments.
A Rutgers University researcher found that dopamine loss causes brain connections to reorganize, leading to impaired motor control. The study suggests that this permanent change may explain why current treatments fail to restore complex movements in Parkinson's disease patients.
The National Institute of Environmental Health Sciences (NIEHS) is launching a $20 million effort to pinpoint environmental triggers of Parkinson's disease. Three centers will conduct independent research, including the University of California at Los Angeles, Emory University, and The Parkinson's Institute.
Emory University will lead a new center studying the relationship between environmental agents and Parkinson's disease, with research focusing on pesticides, organochlorine insecticides, and genetic causes of PD. The center aims to develop strategies for prevention and treatment.
Despite expected global warming impacts, a NASA study reveals an increase in Antarctic sea ice coverage, with the area lengthening by at least one day per year spanning around 5.6 million square kilometers.
A new Medicines Information Helpline has been launched in the UK to provide independent expert advice on medicines for patients with Parkinson's disease. The helpline, staffed by experienced pharmacists, aims to address the need for reliable information on medication management for this growing population.
A study by the American Academy of Neurology found that individuals with depression are more likely to develop Parkinson's disease than those without depression. The researchers suggest that low levels of serotonin in the brain may contribute to both depression and Parkinson's disease, increasing the risk of developing the latter.
Computer model simulates brain cell firing patterns to explain Parkinson's tremors. The model suggests that a synchronized pattern of signals, rather than just increased frequency, is responsible for the characteristic tremors of the disease.
Researchers found significant loss of sympathetic nerve endings in patients with Parkinson's disease (PD), even those without orthostatic hypotension. The study suggests that PD is caused by widespread sympathetic nerve damage, unrelated to treatment with levodopa.
A study by American Academy of Neurology found that rivastigmine significantly reduced hallucinations and improved cognitive abilities in Parkinson's patients. The medication also showed benefits in reaction times, attention, and caregiver distress.
Researchers found that Parkinson's patients who developed dementia had a significantly higher risk of death, regardless of hallucination or depression status. The study also revealed that incident dementia and disease severity were independently associated with an increased risk of mortality.
Researchers at Emory University Health Sciences Center have found a potential link between low testosterone levels and non-motor symptoms of Parkinson's disease in men. Testosterone replacement therapy showed significant improvement in patients with refractory symptoms, including fatigue, depression, anxiety, and decreased libido.
A study of 32 patients with advanced Parkinson's disease found that fetal cell transplants improved symptoms, with the effects being directly proportional to the results experienced prior to transplant. The transplants also showed a significant improvement in dopamine activity in the brain, which stabilized over time.
A Phase I trial has shown that retinal cell implantation can improve motor function in advanced Parkinson's disease patients by nearly 50 percent, according to researchers at Emory University. The implanted cells provide a source of increased dopamine production, helping to alleviate symptoms such as tremors and stiffness.
A study found that green tea extract polyphenol can block the uptake of dopamine, providing a potential protective mechanism against Parkinson's disease. The results suggest that polyphenol can inhibit the uptake of dopamine or neurotoxin MPP+ by blocking dopamine transporter.
A study led by Kenneth Marek found that pramipexole slows dopaminergic neuronal degeneration compared to levodopa in early Parkinson's patients. Most patients will be treated with both medications, and further research is needed to assess the clinical impact of these findings.
Researchers successfully treated rats with chemical-induced Parkinson's disease using gene therapy, restoring normal limb movement. The treatment involves delivering two corrective genes into a specific brain region to prime the production of dopamine, which coordinates limb movements.
Despite being a significant advancement in Parkinson's disease treatment, only 7% of eligible patients in G5 European countries have received deep brain stimulation therapy. Inconsistent funding support and low awareness among general practitioners are major barriers to access.
The Michael J. Fox Foundation awards a $10 million grant to Jeffrey Kordower, PhD, of Rush University Medical Center, to develop embryonic stem cell lines for Parkinson's disease treatment. The goal is to create dopaminergic cells that can be used in research and potentially lead to new treatments.
Two women with Parkinson's disease experienced hair loss while on dopamine agonists pramipexole and ropinirole. After discontinuing these medications and switching to new treatments, their hair growth resumed in both cases.